LONDON: Pharmaceutical company AstraZeneca said Tuesday it will release further data "within 48 hours" on trials in the United States of its Covid-19 vaccine, after health officials raised concerns about initial information disclosed.
"We have reviewed the preliminary assessment of the primary analysis and the results were consistent with the interim analysis," the company said in a statement.
"We intend to issue results of the primary analysis within 48 hours."
Comments
Comments are closed for this article.